entertainment -WSS

entertainment

author：fashion 2025-08-25 07:30:30 - browse：3522

Thomas Massie -- health policy coverage from STAT — Rep. Thomas Massie (R-Ky.) Kevin Dietsch/Getty Images

WASHINGTON — House lawmakers late Tuesday voted to attach a U.S. ban on controversial infectious disease research to legislation that could ultimately fund federal health agencies like the National Institutes of Health.

The bill would bar any federal agencies from funding so-called gain-of-function research, which involves altering a pathogen to study its spread, potentially making it more transmissible or severe in the process.

The spending bill already included a restriction on funding this research in any country determined to be a “foreign adversary,” including China. Scientists at the Wuhan Institute of Virology studied gain-of-function in some viruses, fueling theories that the Covid-19 pathogen was a lab leak. Those theories have never definitively been proven.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： 6 solutions to address cancer drug shortages and others

explore

WSS

The Karikó problem: Lessons for funding basic research

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

2023 Nobel Prize in Medicine goes to Karikó and Weissman

6 solutions to address cancer drug shortages and others

The woman behind the Dana Farber

CDC picks Alphabet's Verily for wasterwater surveillance contract

hotspot

entertainment

hotspot

Peter Hotez and the public health issue of online harassment

Some top drug companies are starting to take action on climate

Tori Bowie and the unacceptable rates of Black maternal death

Pfizer plans to depart BIO

Apple is now the first public company to be valued at $3 trillion

FDA approves world's first CRISPR

As demand for Covid shots wanes, Moderna seeks its next success

CMS should re

After affirmative action ruling, medical educators look to 'holistic review'

The United States is paying nearly triple for new Covid vaccines

hotspot

IVG is promising — but it won’t replace IVF quite yet

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Nobel honors Karikó and Weissman's enduring partnership

FDA needs staff influx to meet gene therapy needs, Marks says

Why sickle cell disease is getting the first CRISPR treatment

Nobel honors Karikó and Weissman's enduring partnership

explore

Wikipedia

explore

entertainment